These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of intraoperative 6% balanced hydroxyethyl starch (130/0.4) during cardiac surgery on transfusion requirements. Hans GA, Ledoux D, Roediger L, Hubert MB, Koch JN, Senard M. J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):328-32. PubMed ID: 25440623 [Abstract] [Full Text] [Related]
3. Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study. Lagny MG, Roediger L, Koch JN, Dubois F, Senard M, Donneau AF, Hubert MB, Hans GA. J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):869-75. PubMed ID: 26774199 [Abstract] [Full Text] [Related]
4. Impact of 6% balanced hydroxyethyl starch following cardiopulmonary bypass on renal function: a retrospective study. Lim JY, Kim YS, Kim JB. J Cardiothorac Surg; 2020 Sep 07; 15(1):237. PubMed ID: 32894168 [Abstract] [Full Text] [Related]
5. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Kasper SM, Meinert P, Kampe S, Görg C, Geisen C, Mehlhorn U, Diefenbach C. Anesthesiology; 2003 Jul 07; 99(1):42-7. PubMed ID: 12826840 [Abstract] [Full Text] [Related]
10. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis. Van der Linden P, Dumoulin M, Van Lerberghe C, Torres CS, Willems A, Faraoni D. Crit Care; 2015 Mar 17; 19(1):87. PubMed ID: 25886765 [Abstract] [Full Text] [Related]
11. Clinical impact of disinvestment in hydroxyethyl starch for patients undergoing coronary artery bypass surgery: a retrospective observational study. Hong M, Jones PM, Martin J, Kiaii B, Arellano R, Cheng D, John-Baptiste AA. Can J Anaesth; 2019 Jan 17; 66(1):25-35. PubMed ID: 30411246 [Abstract] [Full Text] [Related]
13. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A. Anesth Analg; 2009 Dec 17; 109(6):1752-62. PubMed ID: 19923501 [Abstract] [Full Text] [Related]
15. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature. Serpa Neto A, Veelo DP, Peireira VG, de Assunção MS, Manetta JA, Espósito DC, Schultz MJ. J Crit Care; 2014 Feb 17; 29(1):185.e1-7. PubMed ID: 24262273 [Abstract] [Full Text] [Related]
16. Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Sirieix D, Hongnat JM, Delayance S, D'Attellis N, Vicaut E, Bérrébi A, Paris M, Fabiani JN, Carpentier A, Baron JF. Crit Care Med; 1999 Oct 17; 27(10):2159-65. PubMed ID: 10548199 [Abstract] [Full Text] [Related]
17. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review. Hand WR, Whiteley JR, Epperson TI, Tam L, Crego H, Wolf B, Chavin KD, Taber DJ. Anesth Analg; 2015 Mar 17; 120(3):619-626. PubMed ID: 25036375 [Abstract] [Full Text] [Related]